Literature DB >> 26656659

Cytokines in rheumatoid arthritis - shaping the immunological landscape.

Iain B McInnes1,2, Christopher D Buckley3,2, John D Isaacs4,2.   

Abstract

Cytokine-mediated pathways are central to the pathogenesis of rheumatoid arthritis (RA). The purpose of this short Opinion article is to briefly overview the roles of cytokine families in the various phases and tissue compartments of this disease. In particular, we consider the combinatorial role played by cytokines in mediating the overlapping innate and adaptive immune responses associated with disease onset and persistence, and also those cytokine pathways that, in turn, drive the stromal response that is critical for tissue localization and associated articular damage. The success of cytokine inhibition in the clinic is also considerable, not only in offering remarkable therapeutic advances, but also in defining the hierarchical position of distinct cytokines in RA pathogenesis, especially IL-6 and TNF. This hierarchy, in turn, promises to lead to the description of meaningful clinical endotypes and the consequent possibility of therapeutic stratification in future.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26656659     DOI: 10.1038/nrrheum.2015.171

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


  43 in total

Review 1.  Innate lymphoid cells: emerging insights in development, lineage relationships, and function.

Authors:  Hergen Spits; Tom Cupedo
Journal:  Annu Rev Immunol       Date:  2012-01-06       Impact factor: 28.527

Review 2.  The interleukin-1 family: back to the future.

Authors:  Cecilia Garlanda; Charles A Dinarello; Alberto Mantovani
Journal:  Immunity       Date:  2013-12-12       Impact factor: 31.745

Review 3.  TNF biology, pathogenic mechanisms and emerging therapeutic strategies.

Authors:  George D Kalliolias; Lionel B Ivashkiv
Journal:  Nat Rev Rheumatol       Date:  2015-12-10       Impact factor: 20.543

Review 4.  Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges.

Authors:  Josef S Smolen; Daniel Aletaha
Journal:  Nat Rev Rheumatol       Date:  2015-02-17       Impact factor: 20.543

Review 5.  Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis.

Authors:  Giulia Benedetti; Pierre Miossec
Journal:  Eur J Immunol       Date:  2014-02       Impact factor: 5.532

6.  A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis.

Authors:  J van Holten; K Pavelka; J Vencovsky; H Stahl; B Rozman; M Genovese; A J Kivitz; J Alvaro; G Nuki; D E Furst; G Herrero-Beaumont; I B McInnes; P Musikic; P P Tak
Journal:  Ann Rheum Dis       Date:  2004-07-08       Impact factor: 19.103

Review 7.  Th17 cytokines and arthritis.

Authors:  Erik Lubberts
Journal:  Semin Immunopathol       Date:  2010-02-04       Impact factor: 9.623

8.  Synovial fibroblasts spread rheumatoid arthritis to unaffected joints.

Authors:  Stephanie Lefèvre; Anette Knedla; Christoph Tennie; Andreas Kampmann; Christina Wunrau; Robert Dinser; Adelheid Korb; Eva-Maria Schnäker; Ingo H Tarner; Paul D Robbins; Christopher H Evans; Henning Stürz; Jürgen Steinmeyer; Steffen Gay; Jürgen Schölmerich; Thomas Pap; Ulf Müller-Ladner; Elena Neumann
Journal:  Nat Med       Date:  2009-11-08       Impact factor: 53.440

Review 9.  Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases.

Authors:  Daniella M Schwartz; Michael Bonelli; Massimo Gadina; John J O'Shea
Journal:  Nat Rev Rheumatol       Date:  2015-12-03       Impact factor: 20.543

10.  Interleukin-35 induces regulatory B cells that suppress autoimmune disease.

Authors:  Ren-Xi Wang; Cheng-Rong Yu; Ivy M Dambuza; Rashid M Mahdi; Monika B Dolinska; Yuri V Sergeev; Paul T Wingfield; Sung-Hye Kim; Charles E Egwuagu
Journal:  Nat Med       Date:  2014-04-17       Impact factor: 53.440

View more
  134 in total

Review 1.  Molecular insights into phytochemicals exhibiting anti-arthritic activity: systematic review : John Di Battista.

Authors:  P Sivasakthi; E Sanmuga Priya; P Senthamil Selvan
Journal:  Inflamm Res       Date:  2021-05-24       Impact factor: 4.575

2.  Elevated circulating T cell subsets and cytokines expression in patients with rheumatoid arthritis.

Authors:  Haiyan Zhou; Bailong Hu; Zheng Zhaopeng; Jun Liu; Qin Zhong; Youyang Fan; Long Li
Journal:  Clin Rheumatol       Date:  2019-02-26       Impact factor: 2.980

3.  [Altered serum cytokine expression profile in systemic sclerosis and its regulatory mechanisms].

Authors:  H L Zhu; Q DU; W L Chen; X X Zuo; Q Z Li; S J Liu
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-08-18

Review 4.  Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis.

Authors:  Anca I Catrina; Camilla I Svensson; Vivianne Malmström; Georg Schett; Lars Klareskog
Journal:  Nat Rev Rheumatol       Date:  2016-12-15       Impact factor: 20.543

5.  Slc11a1 (Nramp-1) gene modulates immune-inflammation genes in macrophages during pristane-induced arthritis in mice.

Authors:  Mara A Correa; Tatiane Canhamero; Andrea Borrego; Iana S S Katz; José R Jensen; José Luiz Guerra; Wafa H K Cabrera; Nancy Starobinas; Jussara G Fernandes; Orlando G Ribeiro; Olga M Ibañez; Marcelo De Franco
Journal:  Inflamm Res       Date:  2017-07-01       Impact factor: 4.575

Review 6.  Selected cytokine pathways in rheumatoid arthritis.

Authors:  Mélissa Noack; Pierre Miossec
Journal:  Semin Immunopathol       Date:  2017-02-17       Impact factor: 9.623

Review 7.  TLRs, future potential therapeutic targets for RA.

Authors:  Hatem A Elshabrawy; Abdul E Essani; Zoltán Szekanecz; David A Fox; Shiva Shahrara
Journal:  Autoimmun Rev       Date:  2016-12-15       Impact factor: 9.754

8.  Treatment for Rheumatoid Arthritis and Risk of Alzheimer's Disease: A Nested Case-Control Analysis.

Authors:  Richard C Chou; Michael Kane; Sanjay Ghimire; Shiva Gautam; Jiang Gui
Journal:  CNS Drugs       Date:  2016-11       Impact factor: 5.749

9.  Water-soluble artemisinin derivatives as promising therapeutic immunosuppressants of autoimmune diseases.

Authors:  Heng Li; Jianping Zuo; Wei Tang
Journal:  Cell Mol Immunol       Date:  2017-09-11       Impact factor: 11.530

10.  Immunoexpression of canonical Wnt and NF-κB signaling pathways in the temporomandibular joint of arthritic rats.

Authors:  Luane Macêdo de Sousa; Joana Maria Dos Santos Alves; Conceição da Silva Martins; Karuza Maria Alves Pereira; Paula Goes; Delane Viana Gondim
Journal:  Inflamm Res       Date:  2019-08-01       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.